當(dāng)前位置：首頁(yè) SCI期刊 SCIE期刊醫(yī)學(xué) 中科院2區(qū) JCRQ2 期刊介紹(非官網(wǎng))

UrolithiasisSCIE

國(guó)際簡(jiǎn)稱：UROLITHIASIS 參考譯名：尿石癥

中科院分區(qū)
2區(qū)
CiteScore分區(qū)
Q2
JCR分區(qū)
Q2

基本信息：: ISSN：2194-7228; E-ISSN：2194-7236; 是否OA：未開放; 是否預(yù)警：否; TOP期刊：是

出版信息：: 出版地區(qū)：UNITED STATES; 出版商：Springer Berlin Heidelberg; 出版語(yǔ)言：English; 出版周期：6 issues per year; 出版年份：1973; 研究方向：UROLOGY & NEPHROLOGY

評(píng)價(jià)信息：: 影響因子：2; H-index：55; CiteScore指數(shù)：4.5; SJR指數(shù)：0.803; SNIP指數(shù)：1.181

發(fā)文數(shù)據(jù)：: Gold OA文章占比：22.49%; 研究類文章占比：96.94%; 年發(fā)文量：98; 自引率：0.0645...; 開源占比：0.1958; 出版撤稿占比：0; 出版國(guó)人文章占比：0.14; OA被引用占比：0.1531...

投稿咨詢加急見刊

英文簡(jiǎn)介期刊介紹 CiteScore數(shù)據(jù) 中科院SCI分區(qū) JCR分區(qū) 發(fā)文數(shù)據(jù) 常見問題

英文簡(jiǎn)介Urolithiasis期刊介紹

Official Journal of the International Urolithiasis Society

The journal aims to publish original articles in the fields of clinical and experimental investigation only within the sphere of urolithiasis and its related areas of research. The journal covers all aspects of urolithiasis research including the diagnosis, epidemiology, pathogenesis, genetics, clinical biochemistry, open and non-invasive surgical intervention, nephrological investigation, chemistry and prophylaxis of the disorder. The Editor welcomes contributions on topics of interest to urologists, nephrologists, radiologists, clinical biochemists, epidemiologists, nutritionists, basic scientists and nurses working in that field.

Contributions may be submitted as full-length articles or as rapid communications in the form of Letters to the Editor. Articles should be original and should contain important new findings from carefully conducted studies designed to produce statistically significant data. Please note that we no longer publish articles classified as Case Reports. Editorials and review articles may be published by invitation from the Editorial Board. All submissions are peer-reviewed. Through an electronic system for the submission and review of manuscripts, the Editor and Associate Editors aim to make publication accessible as quickly as possible to a large number of readers throughout the world.

期刊簡(jiǎn)介Urolithiasis期刊介紹

《Urolithiasis》自1973出版以來(lái)，是一本醫(yī)學(xué)優(yōu)秀雜志。致力于發(fā)表原創(chuàng)科學(xué)研究結(jié)果，并為醫(yī)學(xué)各個(gè)領(lǐng)域的原創(chuàng)研究提供一個(gè)展示平臺(tái)，以促進(jìn)醫(yī)學(xué)領(lǐng)域的的進(jìn)步。該刊鼓勵(lì)先進(jìn)的、清晰的闡述，從廣泛的視角提供當(dāng)前感興趣的研究主題的新見解，或?qū)彶槎嗄陙?lái)某個(gè)重要領(lǐng)域的所有重要發(fā)展。該期刊特色在于及時(shí)報(bào)道醫(yī)學(xué)領(lǐng)域的最新進(jìn)展和新發(fā)現(xiàn)新突破等。該刊近一年未被列入預(yù)警期刊名單，目前已被權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，得到了廣泛的認(rèn)可。

該期刊投稿重要關(guān)注點(diǎn)：

預(yù)計(jì)審稿時(shí)間：
國(guó)際TOP期刊
醫(yī)學(xué)
UROLOGY & NEPHROLOGY
SCIE
中科院2區(qū)
非預(yù)警

Cite Score數(shù)據(jù)（2024年最新版）Urolithiasis Cite Score數(shù)據(jù)

CiteScore：4.5
SJR：0.803
SNIP：1.181

學(xué)科類別	分區(qū)	排名	百分位
大類：Medicine 小類：Urology	Q2	33 / 120	72%

CiteScore 是由Elsevier(愛思唯爾)推出的另一種評(píng)價(jià)期刊影響力的文獻(xiàn)計(jì)量指標(biāo)。反映出一家期刊近期發(fā)表論文的年篇均引用次數(shù)。CiteScore以Scopus數(shù)據(jù)庫(kù)中收集的引文為基礎(chǔ)，針對(duì)的是前四年發(fā)表的論文的引文。CiteScore的意義在于，它可以為學(xué)術(shù)界提供一種新的、更全面、更客觀地評(píng)價(jià)期刊影響力的方法，而不僅僅是通過影響因子(IF)這一單一指標(biāo)來(lái)評(píng)價(jià)。

歷年Cite Score趨勢(shì)圖

中科院SCI分區(qū)Urolithiasis 中科院分區(qū)

中科院 2023年12月升級(jí)版 綜述期刊：否 Top期刊：否

大類學(xué)科	分區(qū)	小類學(xué)科	分區(qū)
醫(yī)學(xué)	2區(qū)	UROLOGY & NEPHROLOGY 泌尿?qū)W與腎臟學(xué)	2區(qū)

中科院分區(qū)表 是以客觀數(shù)據(jù)為基礎(chǔ)，運(yùn)用科學(xué)計(jì)量學(xué)方法對(duì)國(guó)際、國(guó)內(nèi)學(xué)術(shù)期刊依據(jù)影響力進(jìn)行等級(jí)劃分的期刊評(píng)價(jià)標(biāo)準(zhǔn)。它為我國(guó)科研、教育機(jī)構(gòu)的管理人員、科研工作者提供了一份評(píng)價(jià)國(guó)際學(xué)術(shù)期刊影響力的參考數(shù)據(jù)，得到了全國(guó)各地高校、科研機(jī)構(gòu)的廣泛認(rèn)可。

中科院分區(qū)表 將所有期刊按照一定指標(biāo)劃分為1區(qū)、2區(qū)、3區(qū)、4區(qū)四個(gè)層次，類似于“優(yōu)、良、及格”等。最開始，這個(gè)分區(qū)只是為了方便圖書管理及圖書情報(bào)領(lǐng)域的研究和期刊評(píng)估。之后中科院分區(qū)逐步發(fā)展成為了一種評(píng)價(jià)學(xué)術(shù)期刊質(zhì)量的重要工具。

歷年中科院分區(qū)趨勢(shì)圖

JCR分區(qū)Urolithiasis JCR分區(qū)

2023-2024 年最新版

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：UROLOGY & NEPHROLOGY	SCIE	Q2	61 / 126	52%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：UROLOGY & NEPHROLOGY	SCIE	Q2	40 / 126	68.65%

JCR分區(qū)的優(yōu)勢(shì)在于它可以幫助讀者對(duì)學(xué)術(shù)文獻(xiàn)質(zhì)量進(jìn)行評(píng)估。不同學(xué)科的文章引用量可能存在較大的差異，此時(shí)單獨(dú)依靠影響因子(IF)評(píng)價(jià)期刊的質(zhì)量可能是存在一定問題的。因此，JCR將期刊按照學(xué)科門類和影響因子分為不同的分區(qū)，這樣讀者可以根據(jù)自己的研究領(lǐng)域和需求選擇合適的期刊。

歷年影響因子趨勢(shì)圖

發(fā)文數(shù)據(jù)

2023-2024 年國(guó)家/地區(qū)發(fā)文量統(tǒng)計(jì)

國(guó)家/地區(qū)數(shù)量
CHINA MAINLAND47
USA45
Turkey41
England29
Italy24
GERMANY (FED REP GER)15
Japan10
Sweden10
France9
India9

本刊中國(guó)學(xué)者近年發(fā)表論文

1、An overview of global research landscape in etiology of urolithiasis based on bibliometric analysis
Author: Dong, Caitao; Song, Chao; He, Ziqi; Liao, Wenbiao; Song, Qianlin; Xiong, Yunhe; Meng, Lingchao; Yang, Sixing

Journal: UROLITHIASIS. 2023; Vol. 51, Issue 1, pp. -. DOI: 10.1007/s00240-023-01447-1
2、Stone attenuation on computer tomography helps surgeons make decisions between miniaturized percutaneous nephrolithotomy or retrograde intrarenal surgery for lower pole stones: a retrospective study
Author: Zhan, Chang-Sheng; Zhang, Cheng; Wang, Jian-Zhong; Fan, Song; Zhao, Lei; Shu, Hong-Min; Hao, Zong-Yao

Journal: UROLITHIASIS. 2023; Vol. 51, Issue 1, pp. -. DOI: 10.1007/s00240-023-01442-6
3、A randomized controlled study of ureteral stent extraction string on patient's quality of life and stent-related complications after percutaneous nephrolithotomy in the prone position
Author: Qi, Yuanjiong; Kong, Hailong; Xing, Haonan; Zhang, Zhihong; Chen, Yue; Qi, Shiyong

Journal: UROLITHIASIS. 2023; Vol. 51, Issue 1, pp. -. DOI: 10.1007/s00240-023-01451-5
4、Knowledge-map analysis of percutaneous nephrolithotomy (PNL) for urolithiasis
Author: Hou, Junhui; Lv, Zongwei; Wang, Yuan; Wang, Xia; Wang, Yibing; Wang, Kefeng

Journal: UROLITHIASIS. 2023; Vol. 51, Issue 1, pp. -. DOI: 10.1007/s00240-023-01406-w
5、A combined model based on CT radiomics and clinical variables to predict uric acid calculi which have a good accuracy
Author: Wang, Zijie; Yang, Guangjie; Wang, Xinning; Cao, Yuanchao; Jiao, Wei; Niu, Haitao

Journal: UROLITHIASIS. 2023; Vol. 51, Issue 1, pp. -. DOI: 10.1007/s00240-023-01405-x
6、Prospective comparison of extracorporeal shock wave lithotripsy versus flexible ureterorenoscopy in patients with non-lower pole kidney stones under the COVID-19 pandemic
Author: Bai, Song; Zhan, Yunhong; Pan, Chunyu; Liu, Gang; Li, Jia; Shan, Liping

Journal: UROLITHIASIS. 2023; Vol. 51, Issue 1, pp. -. DOI: 10.1007/s00240-023-01412-y
7、Ureteroscopic and flexible ureteroscopic lithotripsy: continuation or discontinuation of anticoagulant or antiplatelet drugs? A Chinese survey among urologists
Author: Xu, Zi-Jie; Chen, Lei; Li, Deng; Xu, Chao-Liang; Chen, Fei-Teng; Tang, Qi-Lin; Shao, Yi

Journal: UROLITHIASIS. 2023; Vol. 51, Issue 1, pp. -. DOI: 10.1007/s00240-023-01413-x
8、Development and validation of a predictive model for major complications after extracorporeal shockwave lithotripsy in patients with ureteral stones: based on a large prospective cohort
Author: Na, Lei; Li, Jia; Pan, Chunyu; Zhan, Yunhong; Bai, Song

Journal: UROLITHIASIS. 2023; Vol. 51, Issue 1, pp. -. DOI: 10.1007/s00240-023-01417-7